A total of 51 active ingredients in TwHF were screened and hit by 88 potential targets related to DKD, and kaempferol and VEGFA were represented as the uppermost active ingredient and core gene of TwHF in treating DKD, respectively. The gene discussed is VEGFA; the disease is diabetic kidney disease.